Free Trial
OTC:INLB

Item 9 Labs (INLB) Stock Price, News & Analysis

Item 9 Labs logo

About Item 9 Labs Stock (OTC:INLB)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
13.46 million shs
Market Capitalization
$70 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Item 9 Labs and its competitors with MarketBeat's FREE daily newsletter.

INLB Stock News Headlines

Item 9 Labs Corp
This Could Be the Most Profitable Season of Your Life
Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending.
INLB Item 9 Labs Corp.
See More Headlines

INLB Stock Analysis - Frequently Asked Questions

Item 9 Labs Corp. (OTC:INLB) issued its quarterly earnings results on Monday, May, 16th. The company reported ($0.04) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.01.

Shares of INLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Item 9 Labs investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), PayPal (PYPL), Teladoc Health (TDOC) and Adobe (ADBE).

Company Calendar

Last Earnings
5/16/2022
Today
7/18/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
OTC
Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
Medical Equipment
Current Symbol
OTC:INLB
CIK
1500123
Fax
N/A
Employees
100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$21.76 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
701,919,000
Free Float
562,848,000
Market Cap
$70 thousand
Optionable
Not Optionable
Beta
0.77
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTC:INLB) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners